Neurological Disease

SZ1676 is a derivative of SZ1677, which is a neuromuscular blocking agent.

5HT6-ligand-1 is a potent 5-HT6 receptor ligand with a K_i of 1.43 nM.

CB1 antagonist 1 is an antagonist of CB1 receptor, used in the research of metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, gastrointestinal disorders, and cardiovascular conditions.

Potassium Channel Activator 1 ((2,4-Dimethyl-6-morpholin-4-yl-pyridin-3-yl)-carbamic acid benzyl ester) is a potassium channel activator. Potassium Channel Activator 1 can be used for the study diseases or symptoms of dopaminergic system disorders.

Benzamide Derivative 1 is a benzamide derivative from patent EP0213775A1, compound 18. Benzamide Derivative 1 may be useful in treatment of gastrointestinal disorders.

L791943 is a potent, selective Phosphodiesterase-4 (PDE4) inhibitor with an IC₅₀ of 4.2 nM.

5-HT3 antagonist 1 is a potent and selective antagonist of serotonin 3 (5-HT3) receptor.

Tachykinin angatonist 1 is a neurokinin receptor antagonist extracted from patent US5968923, compound example 32.

Neuromuscular Disorder-Targeting Compound 1 is used in the research of neuromuscular disorders such as symptoms of fibromyalgia syndrome and chronic fatigue syndrome.

5-HT3-In-1 is extracted from patent EP0748807A1, compound example 8. It shows 5-HT3 inhibition activity.

Pareptide monohydrochloride is a melanotropin-inhibiting factor (MIF) metabolically stable analogue.

Fenmetozole Tosylate is an antagonist of the actions of ethanol, also antagonizes α2-adrenergic receptor, and acts as an antidepressant agent.

5-HT3 antagonist 2 is a 5-HT3 receptor antagonist.

Pyridazinediones-derivative-1 has potential in treating neurodegenerative disorders. It shows an ED₅₀ of 2.1 μM for inhibiting glutamate-induced contractions of isolated guineapig ileum.

Alpertine is an antipsychotic agent extracted from patent US 5955459 A.

FG8119 is a novel benzodiazepine agonist extracted from patent US 4745112 A.

BACE-IN-1 (Compound 13) is a substituted lmidazo[1 ,2-a]pyridine derivative which can inhibit β-site amyloid precursor protein-cleaving enzyme (BACE) and that may be useful in the treatment of diseases in which BACE is involved, such as Alzheimer's disease.